≥ 92% of participants will know the current evidence related to post-traumatic stress disorder, risk factors, and treatment options.
CEUFast, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. ANCC Provider number #P0274.
≥ 92% of participants will know the current evidence related to post-traumatic stress disorder, risk factors, and treatment options.
After completing this continuing education course, the participant will be able to meet the following objectives:
Post-Traumatic Stress Disorder (PTSD) is a life-altering condition that may occur following exposure to a dramatic life-changing event or series of such events. It is characterized by difficulty accurately interpreting sensory stimuli's threat value following a traumatic event. The prevalence of PTSD globally is “3.9%, with high-income countries having a higher burden of PTSD compared to low-income countries” (Barber & Aaronson, 2022). We refer to experiences of horror, terror, and threatened (real or perceived) injury with the risk of death as "traumatic." This little word fails to convey the scope of the experience, and it is consistently hard for those who have lived through those terrible events to express the profound feelings and changes they have suffered. This inability to articulate one's feelings and thoughts is especially true when talking with people who, due to a lack of personal experience, may not have full insight into feelings that are often beyond the description of words. This course will help the provider to better understand post-traumatic stress disorder, risk factors, and treatment options.
1980 brought PTSD into recognition by its inclusion in the third edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM) published by the American Psychiatric Association, which defines the grouping of symptoms within the syndrome. Until then, separating posttraumatic stress from the throws of severe grief or depression had been clouded by disagreeing perceptions and competing definitions among professionals in the mental health fields.
Helplessness, fear, and even horror are normal, strong reactions to profound events. When intense, pervasive feelings linger after the event of origin has concluded, we refer to them as "post-trauma" or use the term "post-traumatic event" to acknowledge the lingering turmoil that accompanies the presence of stresses yet to be resolved. The process of resolving these stresses often requires help. PTSD can lead to chronic health conditions and comorbid psychiatric illnesses and increase the risk of suicide (Mann, Marwaha, & Torrico, 2024).
Brooklyn Foreger is a 10-year-old girl living in a suburban community with her parents and a younger sibling (Malachi, age 7). She is in the 5th grade at her local elementary school. Brooklyn was invited to a community carnival bustling with other children and families, with the sounds of laughter, music, and carnival lights. It was a yearly tradition for her family to attend. A sudden loud noise rang out while Brooklyn and her family were waiting in line for the Rocket Ride. Initially, it was mistaken for a fireworks display or a malfunctioning ride. However, within moments, chaos erupted, and people began screaming, running in all directions. Brooklyn’s parents tried to shield her and her younger brother, pulling them to the ground, covering their heads, and trying to escape the danger.
After a few harrowing moments, it became clear that gunshots had been fired very close to where they were standing. Brooklyn’s father tried to direct his young family to a safer area. Brooklyn and her brother were physically unharmed, but Brooklyn was emotionally shaken.
Authorities confirmed the shooting had been a targeted attack, and several people were injured, one person dead.
In the hours following the shooting, Brooklyn was tearful and repeatedly asked questions about what had happened. She expressed feelings of confusion and fear, not fully understanding the situation, only that she was in imminent danger. She had trouble sleeping during the following weeks, refused to attend school, and missed her best friend’s birthday party. She became irritable and easily startled by loud noises. She often complained of headaches and would become so emotionally upset if her parents tried to force her to leave the house that she would vomit and have uncontrollable diarrhea.
PTSD is called the "I cannot stop remembering!" disease. Overall population studies in the United States and Canada found the lifetime occurrence of PTSD ranged from 6.8 to 12.3 percent of the adult population, with women generally having around four times higher rates of lingering traumatization to horrific events (Lanius, Frewen & Brand, 2024: Sareen, 2024). Be aware that no demographic group is completely spared from the risk of PTSD in response to exposure to extreme events. Lingering fear and horror can affect any person, given the right circumstances.
Risk factors associated with the development of PTSD include:
Another important risk factor for the development of PTSD is the locus of control or the amount of control people feel that they have over their behaviors and outcomes. An internal locus of control is the belief that a person can influence their own fate. In contrast,
Whether physical changes to the brain occur from heightened levels of stress hormones, as some believe, or those hormones are merely contributing factors, it is clear that the brains of people with PTSD have been changed during the traumatic event.
Once the immediate danger is over, or at least once the perceived risk has lessened, our body initiates a cascade of chemical reactions designed to "defuse" the reaction fear initiated. This closing down, or damping, of the stress response, is linked to an essential hormone, cortisol.
Research has determined that if your body is low or lacking in the hormone cortisol, you cannot effectively or efficiently shut down the stress reaction prompted by the impulse for flight or fight. Without adequate cortisol, you continue to feel the stress effects caused by adrenaline for much longer.
An Acute Stress Disorder (ASD) occurs in the initial month after a person has experienced, witnessed, or been confronted with an event that threatens physical or psychological injury, death, or great harm. This harm could have been directed toward the individual, targeted others, or affected material objects of great value to that person. One example of this was the loss of the World Trade Center twin towers on September 11, 2001, an occurrence that traumatized an entire nation. When exposed to such an event, especially when it is beyond that person's ability to influence or control realistically, intense feelings of helplessness, fear, or horror may result. The intent in identifying ASD is to limit the development of PTSD, which is diagnosed only after four weeks of symptoms following exposure (Bryant, 2024). It is unclear why some people only experience ASD, and other people progress to PTSD, but some believe that it relates to neurobiological processes (Benedek & West, 2024).
The neurobiological response to psychological trauma depends not only on the “stressor characteristics but also on the factors specific to the individual (Sherin & Nemeroff, 2011)”. Genetic, developmental, and experiential factors predispose people to the development of PTSD. In the last decade, “etiological models have been developed to explain the interplay between biology, environment, and mind in manifesting the disease. Examples of those models include the diathesis-stress and the biopsychosocial models” (Al Jowf et al., 2023). Research supports an association between genetic variants and an increased risk for PTSD, including hypothalamic-pituitary-adrenal axis (HPA) dysfunction, neurotransmitter dysregulation, and alterations in brain circuits (Al Jowf et al., 2023; Lanius, Frewen, & Brand, 2024; Van der Kolk, 2015).
According to Kunimatsu et al. (2020), functional magnetic resonance neuroimaging (fMRI) scans of patients who are experiencing PTSD demonstrate focal atrophy of the gray matter, altered fractional anisotropy, and altered focal neural activity and functional connectivity. Several regions of the brain are impacted by the traumatic event, including the medial and dorsolateral prefrontal cortex, orbitofrontal cortex, insula, lentiform nucleus, amygdala, hippocampus and para-hippocampus, anterior and posterior cingulate cortex, precuneus, cuneus, fusiform and lingual gyri, and the white matter tracts connecting these brain regions. Kunimatsu et al. (2020) found that alterations in the brain seen on fMRI scans support the hypothesis that abnormal fear learning and reactions to a perceived threat are highly correlational to the development of PTSD.
In PTSD, the uniting factor is a lingering memory of feelings, thoughts, or images that remain present for some time following an extreme event. These stored sensations may be re-experienced along with a replay of any physiological reactions felt or experienced during the original event (i.e., racing heart, rapid breathing, feelings of falling, or sensations of being trapped, etc.).
Other clinical manifestations include (American Psychiatric Association, 2013; Lanius, Frewen & Brand, 2024):
The five-item Primary Care PTSD measure and the Posttraumatic Stress Disorder Checklist for the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) have demonstrated good reliability and validity.
Sometimes, things happen to people that are unusually or especially frightening, horrible, or traumatic. For Example:
| |
Have you ever experienced this kind of event? If ‘No,’ screen total = 0; if ‘Yes,’ continue with screening. | YES/NO |
In the past month, have you…. | |
1. Had nightmares about the event(s) or thought about the event(s) when you did not want to? | YES/NO |
2. Tried hard not to think about the event(s) or went out of your way to avoid situations that reminded you of the event(s)? | YES/NO |
3. Been constantly on guard, watchful, or easily startled? | YES/NO |
4. Felt numb or detached from people, activities, or your surroundings? | YES/NO |
5. Felt guilty or unable to stop blaming yourself or others for the event(s) or any problems the event(s) may have caused? | YES/NO |
NOTE: Respondents were asked to answer “yes” or “no” to all items. PTSD: Posttraumatic stress disorder |
There is also a Childhood Trauma Questionnaire (CTQ) for assessing childhood trauma exposure. It is a 28-item self-report assessment for childhood maltreatment and can be completed by adolescents (12 and older) as well as adults (Hagborg, Kalin, & Gerdner, 2022). It can usually be completed within five minutes.
To diagnose posttraumatic stress disorder (PTSD) in individuals older than six years, the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) outlines a comprehensive set of criteria that must be met.
The diagnosis also requires evidence of avoidance behaviors, such as efforts to avoid trauma-related thoughts, feelings, or external reminders. Additionally, there must be negative changes in mood and cognition, including memory gaps, distorted beliefs, persistent negative emotions, diminished interest in activities, detachment from others, or an inability to feel positive emotions.
Alterations in arousal and reactivity are also key diagnostic features. These may include heightened irritability, reckless or self-destructive actions, hypervigilance, exaggerated startle responses, difficulty concentrating, or sleep disturbances.
According to McLaughlin (2024), children are not immune to the prolonged effects of trauma. Younger children, in particular, may respond to trauma in ways that differ from adults.
Children between six and eleven years old may display extreme withdrawal, disruptive behaviors, or difficulty focusing.
Adolescents aged twelve through seventeen years may have responses similar to adults.
No matter the age, those who experience the effects of PTSD report continually reliving the trauma. This reliving can occur in the form of nightmares or disturbing recollections, sensations, or emotions during the day. Sleep problems, depression, and feelings of numbness or detachment are common. Sufferers may lose interest in things they once enjoyed, including experiencing affection. Irritability, increased aggressiveness, and even violence can be new behaviors they did not exhibit before.
Many with PTSD report experiencing distress when seeing events, objects, or persons that remind them of the traumatic event. It is common to avoid key places, situations, or people who provoke recall of events they would like to forget. Dates, such as the anniversary of the triggering event, can be especially difficult.
Ordinary, commonplace events can serve as memory association triggers for intrusive images or flashbacks. A flashback is a disassociation from reality with a reenactment or intensely real memory of the traumatic event. An individual reliving a flashback can experience sounds, smells, images, and even feelings from the original event and often believes that the event is occurring all over again. Flashbacks may last seconds or hours. Rarely, a flashback may last for days.
Treatment for PTSD combines the best therapeutic approaches with medication-based care. As each person and each traumatic event are different, no one approach is applicable for every person requiring treatment.
Cognitive Behavioral Therapy (CBT) is often the therapeutic intervention of choice for those with PTSD. CBT focuses on separating and isolating the intrusive thoughts associated with the production of anxiety and any resulting behaviors. Stimuli that trigger thoughts that promote adverse recollection and reaction are systematically exposed and, where possible, associated with positive responses rather than negative, traumatic ones. CBT helps the individual no longer need to avoid situations or places that remind them of the traumatic event. In most cases, CBT initially begins with one-to-one sessions and the client's use of a journal, audiotapes, or videotape to record their thoughts and insights as they occur each day (Kowalski, Elzanowski & Sliwerski, 2024).
Exposure Therapy (ET) helps patients confront their avoided memories therapeutically. By exposing or reliving the trauma, the patient learns to cope with situations in a healthier manner. Types of exposure therapy include prolonged exposure therapy, which consists of 8-15 sessions of 60 to 90 minutes, which focus on the retelling of the traumatic event and gradual exposure to people, places, and events that were avoided due to the PTSD. Prolonged exposure is more effective in populations who have experienced multiple types of traumas and also struggled with comorbidities such as substance use disorder, personality disorder, or psychosis. Written exposure therapy is a brief therapy where patients write out their traumatic event in response to a specific prompt. The therapist then discusses the writings and encourages the patient to closely monitor the emotions and thoughts the writings evoke. In vivo exposure is another form of exposure therapy whereby the patient is confronted with a real-life, mostly safe situation that is typically avoided because it reminds the patient of the traumatic event. An example is driving over a bridge if the trauma involves a car crash on a bridge (Haryadi et al., 2024; Racz et al., 2024).
Eye movement Desensitization and Reprocessing (EMDR) is a form of psychotherapy that mixes components of CBT and exposure therapy while incorporating saccadic eye movements during exposure to the traumatic event(s). The patient reimagines the traumatic scene, focusing on the physical response to the event as well as the mental response. At the same time, the therapist moves two fingers across the patient’s visual field. The patient tracks the therapist’s fingers with his/her eyes while revisualizing the event. This sequence is repeated until anxiety decreases. The patient is encouraged to generate a more adaptive cognitive thought at this point. For example, instead of saying, “I’m going to die!” the patient might say, “I made it through this event. It’s now in the past, and I am safe.” Research supports the idea that EMDR therapy is highly effective in the treatment of PTSD and is rapidly becoming the gold standard for treatment. The drawback is that therapists must be specially trained to perform this type of therapy.
Group Therapy is often used exclusively or as a component of the overall treatment. Survivors can achieve some understanding and resolution of their trauma within the safety, cohesion, and empathy of a group of people who truly understand how it is to feel the shame, guilt, rage, fear, doubt, and self-condemnation of PTSD. Not everyone will benefit from Group Therapy. Be alert for clients who are too early in their recovery to be exposed to a group setting and those who may never be ready for this step.
Psychodynamic psychotherapy explores the emotional conflicts caused by a traumatic event, particularly as they relate to childhood and early life experiences (Kehn, Milrod & Chen, 2024). Retelling the event from the perspective of one who experienced it to a (and here is the key) calm, empathic, compassionate, nonjudgmental therapist, the survivor of the event can build self-esteem, confidence, and better ways of thinking, coping, and living. The primary goal of this form of therapy is to modify the emotional impact of the patient’s traumatic experiences by making this impact more understandable to the patient. Gentle guidance in this journey is offered as needed should the therapist feel the timing and ability to cope are right.
Reducing the risks for the development of PTSD after a major traumatic event such as an earthquake, fire, or mass shooting has come to the forefront of psychiatry. Research in this emerging area is minimal, but the few studies that have been done have shown promising results. The theory of post-traumatic growth (PTG) suggests that deliberate rumination of the event is a positive predictor of the development of post-traumatic stress disorder, where self-efficacy plays a buffer role in decreasing the risk (Xu et al., 2023). Three interventions that were utilized post-disaster include journaling, creative writing, and yoga. All three interventions were reported to decrease the risk of post-traumatic growth and build resilience in populations affected by the event (Susanti et al., 2024).
Selective serotonin reuptake inhibitors (SSRIs) are considered first-line treatment for depression related to PTSD. Several different SSRIs are on the market today, and all have a similar efficacy, differing only in pharmacokinetics, drug interactions, and side effect profile. Most of these medications are well tolerated but can cause dose-related side effects such as headaches, loose stools, decreased libido, and, in some cases, anxiety, agitation, and mania (Stein, 2024).
Serotonin-norepinephrine reuptake inhibitors (SNRIs) treat depression related to PTSD by blocking the presynaptic serotonin and norepinephrine transporter proteins, increasing the stimulation of postsynaptic receptors. Common side effects of this drug class include nausea, dizziness, and diaphoresis. Other side effects that may occur include an increase in blood pressure, headaches, sexual dysfunction, hyponatremia, and an increase in bleeding time (Nelson, 2024; Stein, 2024).
Alpha-adrenergic receptor blockers (Prazosin) were patented in 1965 and initially used to treat hypertension. The Veterans Administration used this drug extensively, and after the Vietnam War, soldiers were prescribed this medication for the treatment of benign prostatic hyperplasia and hypertension. When these soldiers came in for their follow-up appointments, they reported a significant reduction, and in some cases, full resolution of combat-related nightmares. It’s unclear how the medication works, but it is theorized that Prazosin blunts the response to disturbing dreams by decreasing the arousal of alpha-1 adrenoceptors, resulting in a decreased physical response to the traumatic dream (Soh & Tay, 2024; Stein, 2024).
People who experience extreme trauma may suffer an acute loss of contact with reality, hallucinations, delusions, and/or disorganized speech or behavior for a period of time after the event. In these situations, low-dose second-generation antipsychotics (SGAs) are often needed to restabilize the client. These medications work by blocking dopamine D2 receptors. Notable side effects of SGAs include weight gain, increased risk for stroke, diabetes, and tardive dyskinesia (Jibson, 2024). These drugs are often used as combination therapy with either an SSRI or SNRI and are an effective treatment to reduce or eliminate anxiety and psychosis.
Post-traumatic stress disorder (PTSD) is a severely debilitating mental illness with a high dropout rate for treatment. Three specific psychedelics, substances that can induce an altered state of consciousness and cause hallucinations, in combination with therapy, are being used in research for the treatment of PTSD (Henner, Keshavan, & Hill, 2022; Stein, 2024). These include Ketamine, Psilocybin, and MDMA. These substances offer the hope of a new treatment with rapid onset and enduring efficacy that could outpace other psychiatric treatments (Barber & Aaronson, 2022).
Ketamine has shown moderate to large benefits with N-methyl-D-aspartate (NMDA) receptor antagonists, but the long-term risks and benefits are unknown. Research suggests that Ketamine can rapidly improve depressive symptoms associated with PTSD. In a study by Almeida et al. (2024), significant improvement in PCL-5 scores was noted both 24 hours after the initial infusion and at the end of a 1-4 week course of treatment. Even a single intravenous (IV) dose of ketamine has been shown to facilitate a rapid reduction in PTSD symptoms (Fremont et al., 2023). Although the mechanism by which ketamine may improve PTSD symptoms is unclear, studies have suggested that ketamine treatment facilitates neuroplasticity (the ability of the brain to change and adapt over time) and can enhance activity in the prefrontal cortex (Fremont et al., 2023).
Psilocybin is a Schedule I substance that is being studied in randomized Phase II trials for the treatment of unipolar depression, treatment-resistant depression, and PTSD. It is a plant alkaloid derived from a variety of species of mushrooms (Choi et al., 2024). Currently, psilocybin is used for mood disorders, as studies have focused on the treatment of depression and anxiety rather than PTSD; however, studies are being conducted examining the role of psilocybin in the treatment of PTSD (Choi et al., 2024). Proposed mechanisms for the therapeutic effects of psilocybin include modulating neurotransmitters and neuroplasticity (Choi et al., 2024).
Psilocybin acts on many of the same areas of the brain in patients with PTSD. It acts as a partial agonist of serotonin, similar to traditional SSRIs (Choi et al., 2024). It has also been shown, in vivo and in vitro, to create neuroplastic changes and neuritogenesis and spinogenesis(the formation of new neurites and dendrites in neurons) in the brain. Like other psychedelics, psilocybin has been shown to have an effect on emotional modulation, “decreasing the ego defenses, release of unconscious materials and affective load, increased insight into the impact of traumatic event on the creation of maladaptive ego defenses, facilitation of transference, and synthesizing traumatic experiences into a more flexible character structure (Buchborn et al., 2023).” On the other hand, it can also provoke intense anxiety and dysphoria (Barber & Aaronson, 2022). Although the drug remains illegal in most states, Colorado and Oregon have legalized the use of psilocybin therapy, with more states introducing bills in 2024 (Healthe Systems, 2024).
3,4-Meethylenedioxymethamphetamine (MDMA) is a Schedule I synthetic amphetamine derivative that is only approved for use in research settings or expanded access (e.g., granted for compassionate use). It works on neurotransmitter systems, including norepinephrine, serotonin, dopamine, and oxytocin. Currently, this substance is in phase III trials for PTSD and has been shown to work by increasing empathy and decreasing amygdala activation during trauma processing (Henner, Keshavan, & Hill, 2022; Stein, 2024).
It is theorized that psychedelics may change the client’s subjective experience of the trauma along with brain network alterations (aka neurorehabilitation), resulting in significant improvement in PTSD symptoms. The challenge is that all the studies have been small (Dunn et al., 2024; Henner, Keshavan, & Hill, 2022; Stein, 2024).
Brooklyn Foreger’s mother took her to her pediatrician, who referred her to a pediatric psychiatrist. Brooklyn was prescribed Zoloft 25 mg daily as a first-line treatment and assigned a therapist who specialized in trauma therapy. Her parents supported Brooklyn and took the entire family for family therapy sessions. As part of her treatment plan, Brooklyn began drawing pictures and writing in a journal daily. After three months of intense individual therapy, she began to attend group therapy. After six months, she was able to attend school again without having a physical reaction (e.g., diarrhea, nausea, and vomiting).
The U.S. Department of Veterans Affairs (2025a) offers detailed advice on how to best cope with traumatic stress reactions. These include any number of the following:
According to the National Center for PTSD (The U.S. Department of Veterans Affairs, 2025a), four signs that a client is receiving good, evidence-based care for PTSD include the following:
Josef is a 36-year-old sales manager who travels internationally. While traveling in a foreign country, Josef was involved in a head-on collision in a remote area with a van traveling in the wrong lane. The crash resulted in multiple deaths on the bus and left Josef with fractured ribs and a concussion.
During the aftermath of the accident, Josef was trapped in the car for several hours before emergency services arrived. He could hear the cries of other injured victims on the bus, and being unable to help them intensified his feelings of helplessness and guilt. The traumatic event, compounded by intense physical and emotional distress, eventually led to the onset of PTSD.
In the weeks that followed the accident, Josef began to exhibit intrusive thoughts and memories of the event, especially when traveling by car. Mundane stimuli, such as the sound of screeching tires or the smell of exhaust fumes, often triggered these flashbacks. These intrusive memories caused him great distress and made it difficult to focus on work or engage in conversations with his family. He also experienced avoidance behaviors, refused to travel for work trips, and avoided driving when possible. Josef had difficulty sleeping due to nightmares about the accident, often waking up in a state of panic and sweating. He also reported feeling irritable, tense, and hypervigilant, as though he was constantly in danger.
Socially, Josef stopped engaging with friends and avoided events that he once enjoyed. He stopped attending social gatherings and stopped taking vacations, fearing that traveling would trigger memories of the accident. His physical health also began to decline due to disrupted sleep patterns, lack of exercise, and unhealthy coping mechanisms such as alcohol consumption.
Josef sought medication management from a recommended psychiatrist. He was prescribed an SSRI to help decrease his anxiety symptoms, as well as an alpha-1 blocker to decrease his anxiety and treat his nightmares. He was assigned an EMDR therapist who worked with Josef to help process the traumatic memories of the accident, reduce his emotional charge, and integrate these memories into a more adaptive narrative. Both his psychiatrist and his therapist recommended regular exercise, good sleep hygiene, and a reduction in alcohol consumption as part of his treatment plan.
Over time, Josef reported a marked reduction in the intensity of his intrusive thoughts and feelings of guilt. He could resume his travel obligations for work and rebuild his career while continuing to practice his coping skills and manage his stress.
PTSD is a complex disorder characterized by intrusive thoughts, flashbacks, nightmares, hypervigilance, avoidance of places and events that trigger reminders of trauma, and poor sleep, which leads to significant interpersonal dysfunction impacting social and occupational functioning. “The prevalence of PTSD ranges from 6.1 to 9.2 percent in the general adult population for the United States and Canada with one-year prevalence rates of 3.5 to 4.7 percent” (Sareen, 2024). These symptoms may continue for months, even years, after the event. When a situation, individual, or object triggers a flashback, that individual re-experiences aspects of an event in an involuntary and usually very distressing manner. It is important to know they are not weird or abnormal when this occurs. Their thoughts have simply been prompted or triggered to recall the particularly vivid memories instilled by the event.
Feelings of fear, uncertainty, guilt, or dread following a life-threatening, life-altering traumatic event are completely normal. As the body processes stress chemicals released by terror or horror incidents, the mind also seeks to cope. For most, a balance will eventually be restored, though the process is not easy and may not be quick. For some, perhaps as many as thirty percent, of those exposed to traumatic events, balancing the mind, psyche, and emotion will take much longer.
Treatment that combines medication to help lessen symptoms and psychiatric therapy to help the mind accept and adjust to life after the distress-causing event is very helpful for most people. Using coping skills provides means and methods to get through each day, one day at a time.
There is life, health, and happiness after a profound trauma. It may take work to reach it, yet by increasing our knowledge and ability; we can help survivors of horror achieve health without fear.
CEUFast, Inc. is committed to furthering diversity, equity, and inclusion (DEI). While reflecting on this course content, CEUFast, Inc. would like you to consider your individual perspective and question your own biases. Remember, implicit bias is a form of bias that impacts our practice as healthcare professionals. Implicit bias occurs when we have automatic prejudices, judgments, and/or a general attitude towards a person or a group of people based on associated stereotypes we have formed over time. These automatic thoughts occur without our conscious knowledge and without our intentional desire to discriminate. The concern with implicit bias is that this can impact our actions and decisions with our workplace leadership, colleagues, and even our patients. While it is our universal goal to treat everyone equally, our implicit biases can influence our interactions, assessments, communication, prioritization, and decision-making concerning patients, which can ultimately adversely impact health outcomes. It is important to keep this in mind in order to intentionally work to self-identify our own risk areas where our implicit biases might influence our behaviors. Together, we can cease perpetuating stereotypes and remind each other to remain mindful to help avoid reacting according to biases that are contrary to our conscious beliefs and values.